BeneVir Biopharm, Inc.
708 Quince Orchard Rd, Suite 150
Gaithersburg MD 20878
In the emerging field of oncolytic virotherapy, BeneVir is developing an improved therapeutic platform that can be adapted to target a wide variety of cancers. The company is working with leaders in the field to create a pipeline of next generation immunotherapies that will have a significant impact on the fight against cancer.
Powered By GrowthZone